Clinical Trial Update: Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination

View source ↗

Summary

An observational study evaluating long-term outcomes for patients with glaucoma, ocular hypertension, or cataracts treated with the SpyGlass Bimatoprost Implant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma
• Ocular Hypertension

Drugs mentioned

• SpyGlass Bimatoprost Implant System (bimatoprost)

Snippet

Sponsor: SpyGlass Pharma, Inc. | Conditions: Glaucoma, Cataract | Status: ACTIVE_NOT_RECRUITING